Analysis for Prognostic Factors of 60-day Mortality: Evaluation of an Irinotecan-Based Phase III Trial Performed in the First-Line Treatment of Metastatic Colorectal Cancer-Reference-Cited by-同舟云学术

Analysis for Prognostic Factors of 60-day Mortality: Evaluation of an Irinotecan-Based Phase III Trial Performed in the First-Line Treatment of Metastatic Colorectal Cancer

Published:2011-12 Issue:4 Volume:10 Page:317-324
ISSN:1533-0028
Container-title:Clinical Colorectal Cancer
language:en
Short-container-title:Clinical Colorectal Cancer

Author:

Giessen Clemens,Stintzing Sebastian,Laubender Ruediger Paul,Ankerst Donna Pauler,Schulz Christoph,Moosmann Nicolas,Modest Dominik Paul,Schalhorn Andreas,von Weikersthal Ludwig Fischer,Heinemann Volker

Publisher

Elsevier BV

Subject

Gastroenterology,Oncology

Reference39 articles.

1. Sixty-day all-cause mortality rates in patients treated for gastrointestinal cancers, in randomised trials, at the Royal Marsden Hospital;Katopodis;Eur J Cancer,2004

2. Mortality associated with irinotecan plus bolus fluorouracil/leucovorin: summary findings of an independent panel;Rothenberg;J Clin Oncol,2001

3. Pathophysiology and therapy of irinotecan-induced delayed-onset diarrhea in patients with advanced colorectal cancer: a prospective assessment;Saliba;J Clin Oncol,1998

4. CPT-11/Oxaliplatin (L-OHP) Combination Every Two Weeks: Final Results of a Phase I Study in Advanced Digestive Malignancies (Meeting Abstract);Goldwasser;Proc Am Soc Clin Oncol,1999

5. Combination of oxaliplatin plus irinotecan in patients with gastrointestinal tumors: results of two independent phase I studies with pharmacokinetics;Wasserman;J Clin Oncol,1999

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Survival for patients with metastatic colon cancer underwent cytoreductive colectomy in the era of rapid development of anticancer drugs: A real-world analysis based on updated population dataset of 2004–2018;Frontiers in Pharmacology;2022-10-19

2. Impact of age on efficacy and early mortality of initial sequential treatment versus upfront combination chemotherapy in patients with metastatic colorectal cancer: a subgroup analysis of a phase III trial (AIO KRK0110, XELAVIRI study);European Journal of Cancer;2020-09

3. Thymidine phosphorylase gene variant, platelet counts and survival in gastrointestinal cancer patients treated by fluoropyrimidines;Scientific Reports;2014-07-16

4. Tumor markers CEA and CA 19-9 correlate with radiological imaging in metastatic colorectal cancer patients receiving first-line chemotherapy;Tumor Biology;2014-07-15

5. Outcome of patients with metastatic colorectal cancer depends on the primary tumor site (midgut vs. hindgut);Anti-Cancer Drugs;2014-02